The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Event-free survival analysis of the prospectively randomized phase III ETNA study with neoadjuvant nab-paclitaxel (nab-P) versus paclitaxel (P) followed by anthracycline regimens in women with HER2-negative high-risk breast cancer.
 
Luca Gianni
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Celgene; Genenta Science; Genomic Health; Lilly; Merck Sharp & Dohme; Odonate Therapeutics; Oncolytics; Pfizer; Roche; Sandoz; Synaffix
Research Funding - Celgene (Inst)
Patents, Royalties, Other Intellectual Property - Roche
 
Mauro Mansutti
Consulting or Advisory Role - Celgene; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Antonio Anton
Consulting or Advisory Role - Bayer
 
Lourdes Calvo Martínez
No Relationships to Disclose
 
Giancarlo Bisagni
No Relationships to Disclose
 
Begoña Bermejo
Consulting or Advisory Role - Genentech; Novartis
Speakers' Bureau - Genentech; Novartis; Pfizer
 
Vladimir Semiglazov
No Relationships to Disclose
 
Marc Thill
Honoraria - Amgen; AstraZeneca; Celgene; Genomic Health; Hexal; Medtronic; Medtronic; Novartis; Pfizer; pfm medical; Roche; RTI Health Solutions
Consulting or Advisory Role - Amgen; AstraZeneca; Biom'Up; Celgene; Celgene; Eisai; Eisai; Genomic Health; Genomic Health; Lilly; Lilly; MSD Oncology; Neodynamics; Neodynamics; Norgine; Norgine; Novartis; Pfizer; Pfizer; pfm medical; pfm medical; Roche; Roche; RTI Health Solutions; Tesaro
Research Funding - Genomic Health International
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Biom'up; Biom'up; Celgene; Daiichi Sankyo; Eisai; Genomic Health; Hexal; Lilly; Medtronic; Medtronic; Neodynamics; Neodynamics; Norgine; Novartis; Novartis; Pfizer; pfm medical; Roche; Roche/Genentech; RTI Health Solutions; Tesaro
Other Relationship - Amgen; Celgene; Lilly
 
Jose Ignacio Chacon
No Relationships to Disclose
 
Arlene Chan
Honoraria - Amgen; Eisai; Novartis
Consulting or Advisory Role - Lilly; Pfizer; Puma Biotechnology
Speakers' Bureau - Prime Oncology
Research Funding - Eisai
Travel, Accommodations, Expenses - Amgen
 
Serafin Morales
No Relationships to Disclose
 
Isabel Alvarez
Consulting or Advisory Role - AstraZeneca; Novartis; Palex; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Ainhara Lahuerta
No Relationships to Disclose
 
Milvia Zambetti
Speakers' Bureau - Novartis; Pfizer
Travel, Accommodations, Expenses - Celgene; Roche
 
Andrew D. Redfern
Honoraria - Eisai; Novartis; Pfizer; Roche
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Rebecca Alexandra Dent
Honoraria - AstraZeneca; Lilly; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Eisai; Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; Merck; Pfizer; Roche
 
Simona Barlera
No Relationships to Disclose
 
Pinuccia Valagussa
No Relationships to Disclose
 
Ignasi Tusquets
Consulting or Advisory Role - Celgene; Pfizer; Roche
Research Funding - Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche